Cargando…
Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas
SIMPLE SUMMARY: Current therapies for recurrent and metastatic squamous cell carcinomas (SCCs) are associated with poor patient outcomes, and options for later lines of treatment are very limited. In cases where single-agent therapy may be insufficient to eradicate the tumor, thus allowing outgrowth...
Autores principales: | Kessler, Linda, Malik, Shivani, Leoni, Mollie, Burrows, Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582567/ https://www.ncbi.nlm.nih.gov/pubmed/34771475 http://dx.doi.org/10.3390/cancers13215310 |
Ejemplares similares
-
Molecular docking and simulation of Curcumin with Geranylgeranyl Transferase1 (GGTase1) and Farnesyl Transferase (FTase)
por: Subramani, Parasuraman Aiya, et al.
Publicado: (2015) -
CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
por: Malik, Shivani, et al.
Publicado: (2021) -
Molecular characterization of farnesyl pyrophosphate synthase from Bacopa monniera by comparative modeling and docking studies
por: Vishwakarma, Rishi Kishore, et al.
Publicado: (2012) -
Use of Farnesyl Transferase Inhibitors in an Ageing Model in Drosophila
por: Brandt, Annely, et al.
Publicado: (2023) -
Virtual screening and in vitro assay of potential drug like inhibitors from spices against Glutathione-S-Transferase of Meloidogyne incognita
por: Babu, Rosana O, et al.
Publicado: (2012)